News summary

New England Biolabs® and seqWell Announce Strategic Partnership and Commercial Launch of High-Performance TnX® Transposase (Unloaded)

Source: PR Newswire • Published: 15 Oct 2026, 19:00

Summarized by Masters of Longevity from PR Newswire.

Announcement of a strategic partnership and commercial launch of an unloaded engineered transposase for customizable tagmentation workflows and kit integration.

New England Biolabs® and seqWell Announce Strategic Partnership and Commercial Launch of High-Performance TnX® Transposase (Unloaded)
Key Takeaways
  • New England Biolabs secured co-exclusive sales rights and manufacturing rights for seqWell's TnX Transposase (Unloaded).
  • TnX Transposase (Unloaded) is supplied without preloaded adaptors so users can assemble custom transposomes.
  • NEB will sell the unloaded enzyme with optimized loading and reaction protocols and include TnX in NEB kits.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.